Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Germany.
Press releases published on August 5, 2025
HMNC Brain Health Announces Phase 2 Results from OLIVE Trial in Major Depressive Disorder (MDD) with Genetically Guided Precision Approach
GlobeNewswire
·
August 5, 2025
BH-200 (nelivaptan) achieved clinically meaningful reduction in depressive symptoms across the full study population (Difference between BH-200 and placebo in HAM-D17 change from baseline at Week 8: -2.98; p = 0.0003) The largest and most rapid improvement …
Virtune AB (Publ) ("Virtune") has completed the monthly rebalancing for July 2025 of its Virtune Crypto Top 10 Index ETP - the first crypto index ETP in the Nordics
GlobeNewswire
·
August 5, 2025
Stockholm, 5 August 2025 - Virtune today announces the completion of the monthly rebalancing for the Virtune Crypto Top 10 Index ETP, listed on Nasdaq Stockholm for both the SEK-denominated (ISIN code SE0020052207, ticker name VIR10SEK) and the EUR- …
Virtune AB (Publ) (“Virtune”) har genomfört den månatliga rebalanseringen för juli 2025 av Virtune Crypto Top 10 Index ETP, Nordens första kryptoindex-ETP
GlobeNewswire
·
August 5, 2025
Stockholm, 5 augusti 2025 - Virtune meddelar idag att man har slutfört den månatliga rebalanseringen för Virtune Crypto Top 10 Index ETP SEK / EUR som är noterad på Nasdaq Stockholm för både SEK-varianten (ISIN-kod SE0020052207, tickernamn VIR10SEK) och …
Aicuris Presents Pharmacokinetic Data from the First-in-Human Clinical Trial of AIC468, a Novel Antisense Oligonucleotide Targeting BK Virus, at World Transplant Congress
GlobeNewswire
·
August 5, 2025
Initial results from the First in Human (FIH) Phase 1 trial evaluating AIC468, a 2nd generation antisense oligonucleotide (ASO), in healthy volunteers demonstrated favorable pharmacokinetic (PK) characteristics AIC468 was safe and well tolerated in all …